TP53 and breast neoplasm: “Plastic” luminal TIC activities have also been identified in mouse basaloid Wnt1- and p53-induced breast tumors [59], using CD61 as a luminal cell marker, and by our group, using the canonical Wnt receptor, Lrp5 [60].